Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-25T11:01:00.171Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibiothérapie du sujet âgé : On peut toujours mieux faire

Published online by Cambridge University Press:  13 June 2016

Violaine Tolsma ,
Jacques Gaillat  and
Leonardo Pagani Open the ORCID record for Leonardo Pagani [Opens in a new window]
Violaine Tolsma
Affiliation:
Service de Maladies Infectieuses, Centre Hospitalier Annecy-Genevois (CHANGE), Annecy; France.
Jacques Gaillat
Affiliation:
Service de Maladies Infectieuses, Centre Hospitalier Annecy-Genevois (CHANGE), Annecy; France.
Leonardo Pagani*
Affiliation:
Programme de Bon Usage des Antimicrobiens, Centre Hospitalier Annecy-Genevois (CHANGE), Annecy; France. Service de Maladies Infectieuses, Hôpital Central de Bolzano, I-39100, Bolzano; Italie
*
*La correspondance et les demandes de tiré à part doivent être adressées à : / Correspondence and requests for offprints should be sent to: Leonardo Pagani, M.D. Service de Maladies Infectieuses Hôpital Central de Bolzano Bolzano, Italie (lpagani.id@gmail.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

Antimicrobials are among the most prescribed drugs and their prescription increases with age, due to frailty and accrued risk factors for acquiring infections. Antimicrobial prescription in elderly patients must not only account for the risk of toxicity due to drug overexposure, but also of treatment failure or promotion of antimicrobial resistance due to under-dosage. This paper reviews the main antimicrobial, pharmacokinetic and pharmacodynamic variations induced by aging, comorbidities and polypharmacy, and how to take them into account to optimize antimicrobial prescription in elders.

Résumé

Les antibiotiques figurent parmi les traitements les plus fréquemment utilisés et leur prescription augmente avec l’âge, du fait de la fragilité et d’autres facteurs qui augmentent le risque d’infection dans la population gériatrique. La prescription d’un traitement anti-infectieux chez le sujet âgé doit tenir compte du risque de toxicité liée au surdosage mais aussi de celui d’échec ou d’émergence de résistance en cas de sous-dosage. Cet article décrit les principales modifications des paramètres pharmacocinétiques et pharmacodynamiques induites par le vieillissement physiologique, les comorbidités ou la polymédication, et comment les prendre en compte pour optimiser la prescription des antibiotiques.

Keywords

antimicrobialspharmacokineticspharmacodynamicselderly patients (subjects)anti-infectieuxpharmacocinétiquepharmacodynamiesujets âgé
Type
Policy and Practice Notes / Notes sur les politiques et les pratiques
Information
Canadian Journal on Aging / La Revue canadienne du vieillissement , Volume 35 , Issue 3 , September 2016 , pp. 385 - 392
Check for updates
Copyright
Copyright © Canadian Association on Gerontology 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anantharaju, A., Feller, A., & Chedid, A. (2002). Aging liver. A review. Gerontology, 48(6), 343–353.Google Scholar
Andro, M., Estivin, S., Comps, E., & Gentric, A. (2011). Assessment of renal function in elderly after eighty years: Cockroft and Gault or modification of diet in renal disease equation? La Revue de Medecine Interne, 32(11), 698–702.Google Scholar
Aspinall, S. L., Good, C. B., Jiang, R., McCarren, M., Dong, D., & Cunningham, F. E. (2009). Severe dysglycemia with the fluoroquinolones: A class effect? Clinical Infectious Diseases, 49(3), 402–408.Google Scholar
Aymanns, C., Keller, F., Maus, S., Hartmann, B., & Czock, D. (2010). Review on pharmacokinetics and pharmacodynamics and the aging kidney. Clinical Journal of the American Society of Nephrology, 5(2), 314–327.Google Scholar
Benet, L. Z., & Hoener, B. A. (2002). Changes in plasma protein binding have little clinical relevance. Clinical Pharmacology and Therapeutics, 71(3), 115–121.Google Scholar
Bentley, D. W., Bradley, S., High, K., Schoenbaum, S., Taler, G., & Yoshikawa, T. T. (2000). Practice guideline for evaluation of fever and infection in long-term care facilities. Clinical Infectious Diseases, 31(3), 640–653.Google Scholar
Bird, S. T., Etminan, M., Brophy, J. M., Hartzema, A. G., & Delaney, J. A. (2013). Risk of acute kidney injury associated with the use of fluoroquinolones. Canadian Medical Association Journal, 185(10), E475–E482.Google Scholar
Bowie, M. W. & Slattum, P. W. (2007). Pharmacodynamics in older adults: a review. The American Journal of Geriatric Pharmacotherapy, 5(3), 263–303.CrossRefGoogle ScholarPubMed
Chou, H. W., Wang, J. L., Chang, C. H., Lee, J. J., Shau, W. Y., & Lai, M. S. (2013). Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan. Clinical Infectious Diseases, 57(7), 971–980.Google Scholar
Ciccocioppo, R., Di Sabatino, A., Luinetti, O., Rossi, M., Cifone, M. G. & Corazza, G. R. (2002). Small bowel enterocyte apoptosis and proliferation are increased in the elderly. Gerontology, 48(4), 204–208.Google Scholar
Corsonello, A., Abbatecola, A. M., Fusco, S., Luciani, F., Marino, A., Catalano, S., et al. (2015). The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly. Clinical Microbiology and Infection, 21(1), 20–26.CrossRefGoogle ScholarPubMed
Corsonello, A., Pedone, C., & Incalzi, R. A. (2010). Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Current Medicinal Chemistry, 17(6), 571–584.Google Scholar
Craig, W. A. (1998a). Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases, 26(1), 1–10.Google Scholar
Craig, W. A. (1998b). Choosing an antibiotic on the basis of pharmacodynamics. Ear, Nose & Throat Journal, 77(6), 7–11.Google Scholar
Esposito, C., & Dal Canton, A. (2010). Functional changes in the aging kidney. Journal of Nephrology, 23(15), S41–S45.Google ScholarPubMed
Evans, R. S., Lloyd, J. F., Stoddard, G. J., Nebeker, J. R., & Samore, M. H. (2005). Risk factors for adverse drug events: a 10-year analysis. Annals of Pharmacotherapy, 39(7–8), 1161–1168.Google Scholar
Feldman, M. (1997). The mature stomach. Still pumping out acid? The Journal of the American Medical Association, 278(8), 681–682.CrossRefGoogle ScholarPubMed
Fliser, D. (2008). Assessment of renal function in elderly patients. Current Opinion in Nephrology and Hypertension, 17(6), 604–608.Google Scholar
Forbes, G. B., & Reina, J. C. (1970). Adult lean body mass declines with age: some longitudinal observations. Metabolism Clinical and Experimental, 19(9), 653–663.Google Scholar
Fraisse, T., Gras Aygon, C., Paccalin, M., Vitrat, V., De Wazieres, B., Baudoux, V., et al. (2014). Aminoglycosides use in patients over 75 years old. Age & Ageing, 43(5), 676–681.Google Scholar
Garasto, S., Fusco, S., Corica, F., Rosignuolo, M., Marino, A., Montesanto, A., et al. (2014). Estimating glomerular filtration rate in older people. BioMed Research International, 2014, 1–12.Google Scholar
Gavazzi, G., & Krause, K. H. (2002). Ageing and infection. The Lancet Infectious Diseases, 2(11), 659–666.Google Scholar
Grandison, M. K., & Boudinot, F. D. (2000). Age-related changes in protein binding of drugs: implications for therapy. Clinical Pharmacokinetics, 38(3), 271–290.CrossRefGoogle ScholarPubMed
Gregersen, H., Pedersen, J., & Drewes, A. M. (2008). Deterioration of muscle function in the human esophagus with age. Digestive Diseases and Sciences, 53(12), 3065–3070.Google Scholar
Herring, A. R., & Williamson, J. C. (2007). Principles of antimicrobial use in older adults. Clinics in Geriatric Medicine, 23(3), 481–497.CrossRefGoogle ScholarPubMed
Hickson, M. (2006). Malnutrition and ageing. Postgraduate Medical Journal, 82(963), 2–8.Google Scholar
Htwe, T. H., Mushtaq, A., Robinson, S. B., Rosher, R. B., & Khardori, N. (2007). Infection in the elderly. Infectious Disease Clinics of North America, 21(3), 711–743.Google Scholar
Kasiakou, S. K., Lawrence, K. R., Choulis, N., & Falagas, M. E. (2005). Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parameters. Drugs, 65(17), 2499–2511.CrossRefGoogle Scholar
Kirby, J. T., Fritsche, T. R., & Jones, R. N. (2006). Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: Report from the chemotherapy alliance for neutropenics and the control of emerging resistance program (North America). Diagnostic Microbiology & Infectious Disease, 56(1), 75–82.CrossRefGoogle ScholarPubMed
Kyle, U. G., Genton, L., Hans, D., Karsegard, V. L., Michel, J. P., Slosman, D. O., et al. (2001). Total body mass, fat mass, fat-free mass, and skeletal muscle in older people: cross-sectional differences in 60-year-old persons. Journal of the American Geriatrics Society, 49(12), 1633–1640.Google Scholar
Mattappalil, A., & Mergenhagen, K. A. (2014). Neurotoxicity with antimicrobials in the elderly: a review. Clinical Therapeutics, 36(11), 1489–1511.Google Scholar
McLean, A. J., & Le Couteur, D. G. (2004). Aging biology and geriatric clinical pharmacology. Pharmacological Reviews, 56(2), 163–184.Google Scholar
Norman, D. C., & Yoshikawa, T. T. (1996). Fever in the elderly. Infectious Disease Clinics of North America, 10(1), 93–99.Google Scholar
Olivier, P., Bertrand, L., Tubery, M., Lauque, D., Montastruc, J. L., & Lapeyre-Mestre, M. (2009). Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs & Aging, 26(6), 475–482.Google Scholar
Orr, W. C., & Chen, C. L. (2002). Aging and neural control of the GI tract: IV. Clinical and physiological aspects of gastrointestinal motility and aging. American Journal of Physiology Gastrointestinal and Liver Physiology, 283(6), G1226–1231.Google Scholar
Paterson, J. M., Mamdani, M. M., Manno, M., & Juurlink, D. N. (2012). Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. Canadian Medical Association Journal, 184(14), 1565–1570.Google Scholar
Pea, F. (2015). Antimicrobial treatment of bacterial infections in frail elderly patients: the difficult balance between efficacy, safety and tolerability. Current Opinion in Pharmacology, 24, 18–22.Google Scholar
Roberts, J. A., Pea, F., & Lipman, J. (2013). The clinical relevance of plasma protein binding changes. Clinical Pharmacokinetics, 52(1), 1–8.Google Scholar
Rodriguez-Castro, E. M., & Cordova, H. R. (2011). Aging and the kidney. Boletin de la Asociacion Medica de Puerto Rico, 103(3), 57–62.Google Scholar
Rolan, P. E. (1994). Plasma protein binding displacement interactions—Why are they still regarded as clinically important? British Journal of Clinical Pharmocology, 37(2), 125–128.CrossRefGoogle ScholarPubMed
Schmucker, D. L. (2001). Liver function and phase I drug metabolism in the elderly: a paradox. Drugs & Aging, 18(11), 837–851.Google Scholar
Schneitman-McIntire, O., Farnen, T. A., Gordon, N., Chan, J., & Toy, W. A. (1996). Medication misadventures resulting in emergency department visits at and HMO medical center. American Journal of Health-System Pharmacy, 53(12), 1416–1422.Google Scholar
Sera, L. C., & McPherson, M. L. (2012). Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clinics in Geriatric Medicine, 28(2), 273–286.Google Scholar
Shi, S., & Klotz, U. (2011). Age-related changes in pharmacokinetics. Current Drug Metabolism, 12(7), 601–610.Google Scholar
Stahlmann, R., & Lode, H. (2010). Safety considerations of fluoroquinolones in the elderly: an update. Drugs & Aging, 27(3), 193–209.CrossRefGoogle ScholarPubMed
Strausbaugh, L. J., Sukumar, S. R., & Joseph, C. L. (2003). Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clinical Infectious Diseases, 36(7), 870–876.Google Scholar
Teli, M. R., James, O. F., Burt, A. D., Bennett, M. K., & Day, C. P. (1995). The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology, 22(6), 1714–1719.Google Scholar
Van Pottelbergh, G., Van Heden, L., Mathei, C., & Degryse, J. (2010). Methods to evaluate renal function in elderly patients: a systematic literature review. Age & Ageing, 39(5), 542–548.Google Scholar
Zeeh, J., & Platt, D. (2002). The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology, 48(3), 121–127.CrossRefGoogle ScholarPubMed